Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLAR-1: Alpelisib + Fulvestrant in Advanced Breast Cancer
NCT02437318Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of alpelisib in breast cancer, sponsored by Novartis. Started Jul 2015; status: completed.
02
Drugs
alpelisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02437318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437318.